">
Hadassah

Hadassah Cancer Specialists Explore Link Between Colorectal Cancer and BRCA Mutations

Wednesday, Jul 11 2018

Looking further into the link between colorectal cancer and BRCA 1 and 2 genetic mutations, researchers from the Hadassah Medical Center’s Sharett Institute of Oncology, together with colleagues from Chaim Sheba Medical Center, analyzed data from 32 patients with lower gastrointestinal cancers. Nearly 63 percent of the patients were BRCA 1 carriers, and two of the patients also had anal cancer.

Though mucinous tumors are typically rare and are usually situated in the right side of the colon, carriers of the BRCA mutations were more than twice as likely to have mucinous tumors than non-BRCA carriers, and their tumors are mostly on the left side of the colon. According to the researchers, they may also have a better prognosis.

These findings led the researchers to suggest that “Ashkenazi BRCA 1 and 2 mutation carriers with colorectal cancer might have characteristics that are unique to them—that is, for example, a high rate of left-sided cancer, with what is called a mucinous histology, and accompanied by anal cancer.” For that reason, treatment may require different approaches.

The study is highlighted in the January 10, 2018, issue of European Journal of Human Genetics. 

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Jul 11 2018

Improving Kidney Health of Premature Babies

Is the TV hit show Grey's Anatomy taking its inspiration from Hadassah Hospital? After all, cast members did visit Hadassah Ein Kerem in 2011. Dr. Oded Volovelsky, Head of Hadassah's new Pediatric Nephrology Unit says, only half-jokingly, that TV doc Meredith Grey might have read his research.

READ MORE ›
alt_text

Monday, Jul 9 2018

World Hepatitis Day: Hadassah’s Contribution to the Global Battle Against this Disease

“Hadassah Medical Organization's (HMO) greatest contribution to the global battle against Hepatitis are the vaccines that have been developed here,” said Prof. Daniel Shouval, as we mark World Hepatitis Day on July 28.

READ MORE ›
alt_text

Tuesday, Jul 3 2018

Prioritizing Treatment Options in Breast Cancer

When a patient with metastatic breast cancer fails to respond to conventional treatment and gene analysis identifies several targetable molecular mutations, how do you prioritize treatment options?

READ MORE ›
alt_text

Tuesday, Jul 3 2018

In a First, a Baby with a Severe Intestinal Defect Receives Medication That Allows Her to Eat Normally

Administering the lowest possible dosage of a medication never before used on a baby, Dr. Mordechai Slae, a senior pediatric gastroenterologist at Hadassah Medical Center, was able to ameliorate the condition of a 6-month-old baby born with a rare and severe defect in her large intestine.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More